C3511001 Memento 1 - Meningococcal Vaccine Study  

Trauma and PTSD Study: Experiencing feelings of fear, isolation, and vulnerability?  

This will be a 12-week, multicenter, randomized, double-blind trial evaluating the efficacy, safety, and tolerability of investigational drug + sertraline combination treatment in adult subjects

Infant Social Motivation Project

). Participants will complete three online surveys over about 12 months, one at the start of the study and two at a 12 month follow-up. Each survey will last up to 20 minutes. Participants will receive a $5 Amazon

Vaccine Response Eczema Study- Ages 12 and up

For many people living with moderate- to- severe eczema (also called atopic dermatitis or AD), the treatment options currently available do not provide satisfactory relief from itching or other symptoms. Researchers have been studying an investigational drug called nemolizumab to find out if it is both safe and beneficial in …

COPD Research Study for those with currently using inhaled medications (triple therapy) and have required an oral steroid for a flare in breathing 1-2 times in the last 12 months.

This investigational study is enrolling moderate to severe COPD subjects.   To qualify you must be on inhaled maintenance medications and have required oral steroids 1-2 times or a hospitalization in the last year.    Pulmonary function test will be performed and compensation will be provided for those who qualify.  

A phase II randomized, double-blinded, placebo-controlled parallel group trial to examine the efficacy and safety of BI 425809 once daily with adjunctive Computerized Cognitive Training over 12 week treatment period in patients with schizophrenia

This study tests whether BI 425809 together with brain training using a computer improves mental functioning in patients with schizophrenia.  

A 12-month, Prospective, Randomized, Active-controlled, Open-label Study to Evaluate the Patient Retention of Fingolimod vs. Approved First-line Disease Modifying Therapies in Adults Who Are in Early Stages of Treatment for Relapsing Remitting Multiple Sclerosis

A 12-month, Prospective, Randomized, Active-controlled, Open-label Study to Evaluate the Patient Retention of Fingolimod vs. Approved First-line Disease Modifying Therapies in Adults Who Are in Early

A 12-week, Randomized, Double-blind, Parallel-group, Placebo-controlled, Fixed-dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder

A 12-week, Randomized, Double-blind, Parallel-group, Placebo-controlled, Fixed-dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to

A 12-month, Randomized, Rater- and Dose-blinded Study to Compare the Efficacy and Safety of Fingolimod 0.25 mg and 0.5 mg Administered Orally Once Daily With Glatiramer Acetate 20 mg Administered Subcutaneously Once Daily in Patients With Relapsing-remitting Multiple Sclerosis

A 12-month, Randomized, Rater- and Dose-blinded Study to Compare the Efficacy and Safety of Fingolimod 0.25 mg and 0.5 mg Administered Orally Once Daily With Glatiramer Acetate 20 mg Administered

The Effects of a Novel Probiotic Supplement on Menopausal Symptoms

The purpose of this research study is that Lactobacillus brevis HA-112 and Lactobacillus paracasei HA-274, consumed over a 12-week period, will help reduce the symptoms of menopause. &nbsp